|According to the website Online Lawyer Source, the diabetes drug Avandia, has been documented to increase the risk of heart attacks. A pivotal meta analysis study including assessments of 42 clinical trials, was published in the New England Journal of Medicine in 2007, involving almost 28,000 Avandia users.|
The study confirmed that Avandia significantly increased (43%) the risk of heart attack risk in patients being treated for type two diabetes. The drug was taken off of the market in Europe, yet remains on the market in America. Avandia has been in the news the past few weeks as a team known as Duke Clinical Research Institute (DCRI) works to reanalyze the original meta-analysis mentioned above. Sales of Avandia approached $3 billion dollars before the meta-analysis, but sales dropped to about $500 million in 2010.